Blended Solutions
Bespoke, seamless solutions to meet unique sponsor challenges.
Whitepaper: Embracing a blended operating model
Outsourcing encompasses more than half the total global clinical development spend. As a result, the way the industry outsources is evolving to maximise ROI and efficiency amid increasing complexity and difficulty within the clinical development landscape.
Whitepaper: How investments in supply of CRAs is better than competing with the demand for CRAs
In this whitepaper, ICON’s experts address our commitment to four main objectives to reducing the CRA drought.
Whitepaper: The evolution of FSP, not just for large pharma
For mid-size pharma, CRO and FSP models may evolve as the company grows. This either/or decision often means switching models by switching suppliers. By harnessing the ‘Embedded Blended’ model, all sponsors can benefit from a synchronised outsourcing strategy.
Whitepaper: Clinical trials in Japan: An enterprise growth and management strategy
Presenting a unique approach to evolve the traditional local clinical development model in Japan, while lowering costs, improving productivity, and potentially accelerating drug approval timelines.
-
Media article: Blending Models for Better Sourcing Solutions
There is a growing trend among large and midsize pharma in turning toward more strategic partnerships to help them navigate the increasing complexity of the development landscape and the compounding macroeconomic constraints.
-
Media article: Redefining CRO sourcing model terminology to optimise outsourcing strategies
ICON is currently engaging with the Tufts CSDD - with input and in collaboration with ICON’s biopharmaceutical company Partners of Choice (PoC) - and invites input into a proposed new taxonomy and framework to redefine CRO sourcing model terminology.
-
Media article: A blended solution – how midsize pharmaceutical and biotech companies can optimise the delivery of their clinical trials
John Barry, SVP and Chief Strategy Officer of ICON’s Strategic Solutions Division, considers the benefits of a blended model that combines FSP scale and CRO project-based sourcing for mid-size pharmaceutical and biotech companies.
-
Media article: Embedded blended solutions
John Barry and Brian Swindley offer their insights on the options available to pharma companies when delivering their clinical trial portfolios.
-
Media article: A golden opportunity but not a silver bullet
This spotlight feature authored by ICON's Barry Balfe examines how pharmaceutical companies are increasing their functional service partnership expenditure at a rapid rate, and the key considerations in selecting and executing the FSP model which are being overlooked. (PDF)
Blogs
Blended Solutions
ICON provides blended solutions with custom configurations to address sponsor challenges through seamlessly integrated service delivery. ICON combines world-leading global FSP solutions, FSO, standalone, and specialty services for efficiency and control. Expert consultants guide transitions and use formal governance to optimize the benefits of a bespoke, flexible, and efficient model.
Explore our library of case studies to find out how we have increased operating efficiencies for our clients.